Mild obesity appears to improve survival in ALS patients
Patients with amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, may be an exception to the rule that being overweight is a health hazard. In a retrospective study of over 400 ALS patients, Massachusetts General Hospital (MGH) researchers found that those who were mildly obese survived longer than patients who were normal weight, underweight or even overweight. The study will appear in the journal Muscle & Nerve and has been published online.
"We have long known that being underweight shortens survival for ALS patients, and several studies in an animal model have shown that weight gain is associated with increased survival," says Anne-Marie Wills, MD, MPH, of the MGH Neurology Clinical Trials Unit, senior author of the report. "Our study was designed to investigate how cholesterol levels affect survival. We were surprised to find that body mass index or BMI a measure of weight adjusted for height made a large difference in survival. Patients with a BMI of 30 to 35, who would be considered mildly clinically obese, lived the longest; and patients who were overweight, with a BMI of 25 to 30, lived the second longest."
ALS is a progressive neurodegenerative disease affecting motor neurons in the brain and spinal cord. Death of these nerve cells stops the transmission of neural impulses to muscle fibers, leading to weakness, paralysis and usually death from respiratory failure. During the course of their disease ALS patients usually lose even more weight than can be attributed to the loss of muscle mass caused by nerve destruction and the related muscle inactivity. Studies have shown that ALS patients burn more calories than would be expected from their limited physical activity, but the mechanism for this metabolic change is currently unknown.
A previous smaller study suggested that ALS patients with higher levels of low-density lipoprotein (LDL) relative to high-density lipoprotein (HDL) might live longer. In order to test that association in a larger group of patients, the MGH team analyzed data on more than 400 patients who had participated in three clinical trials of potential ALS drugs. Along with the results of initial blood tests taken when participants entered the trials, the researchers had access to follow-up blood tests for almost 200 participants and information on how long each patient survived without needing mechanical ventilation assistance.
Depending on the particular clinical trial, survival data was available for one to two years after study initiation. While higher baseline cholesterol levels were associated with longer survival, that association disappeared when the results were controlled for BMI. As expected, the shortest survival was seen in malnourished or morbidly obese patients, but patients in the mildly obese range had the longest survival of any BMI group.
"While this finding needs further investigation, we hypothesize that it is due to increased energy reserves available to these patients," says Wills, an instructor of Neurology at Harvard Medical School. "We don't know whether actively putting on weight would be helpful, but right now I'm telling my patients with ALS they can eat anything they want."
Provided by Massachusetts General Hospital
- Liver transplant offers survival benefits for patients of all sizes Dec 04, 2007 | not rated yet | 0
- Preserving nerve cells in motor neuron disease Sep 20, 2010 | not rated yet | 0
- New guidelines identify best treatments to help ALS patients live longer, easier Oct 12, 2009 | not rated yet | 0
- Spinal fluid proteins signal Lou Gehrig's disease Jan 28, 2009 | not rated yet | 0
- Lou Gehrig's protein found throughout brain, suggesting effects beyond motor neurons Jun 16, 2008 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011 I'd like to open a discussion thread for version 2 of the draft of my book ''Classical and Quantum Mechanics via Lie algebras'', available online at http://lanl.arxiv.org/abs/0810.1019 , and for the...
- More from Physics Forums - Independent Research
More news stories
Gourmands and foodies everywhere have long recognized ginger as a great way to add a little peppery zing to both sweet and savory dishes; now, a study from researchers at Columbia University shows purified components of the ...
Diseases, Conditions, Syndromes 7 hours ago | not rated yet | 0
There are significant cost and risk factors associated with two procedures commonly used to diagnose or treat gastrointestinal problems, according to research presented at Digestive Disease Week (DDW).
Diseases, Conditions, Syndromes 20 hours ago | not rated yet | 0
Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease ...
Diseases, Conditions, Syndromes 20 hours ago | not rated yet | 0 |
A new case of the deadly coronavirus has been detected in Saudi Arabia where 15 people have already died after contracting it, the health ministry announced on Saturday on its Internet website.
Diseases, Conditions, Syndromes May 18, 2013 | not rated yet | 0
(HealthDay)—Few randomized clinical trials have been done to assess clinical prediction rules for patients with lower back pain, and the trials that have been done are of low quality and do not provide ...
Diseases, Conditions, Syndromes May 17, 2013 | not rated yet | 0 |
Researchers at the University of Wisconsin have identified a potential new risk factor for obstructive sleep apnea: asthma. Using data from the National Institutes of Health (Heart, Lung, and Blood Institute)-funded Wisconsin ...
7 hours ago | not rated yet | 0 |
In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual ...
8 hours ago | 5 / 5 (2) | 0 |
Scientists at Johns Hopkins have turned their view of osteoarthritis (OA) inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, ...
8 hours ago | 5 / 5 (3) | 0 |
A new study looking at sleep-disordered breathing (SDB) and markers for Alzheimer's disease (AD) risk in cerebrospinal fluid (CSF) and neuroimaging adds to the growing body of research linking the two.
8 hours ago | 5 / 5 (1) | 0 |
The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.
12 hours ago | not rated yet | 0
Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...
20 hours ago | 4.8 / 5 (4) | 0 |